Amphastar制药 AMPH 深 沪
已收盘 12-19 16:00:00 美东时间
26.58
+0.080
+0.30%
华盛通- 最 高27.8388
- 今 开26.40
- 成交量 24.42万股
- 最 低 25.16
- 昨 收 26.50
- 总市值 12.98亿
- 52周最高 39.01
- 市盈率 静 21.30
- 换手率 0.50%
- 52周最低 20.385
- 委 比 87.85%
- 总股本 4882.98万
- 历史最高 67.66
- 量 比 0.71
- 振 幅 10.11%
- 历史最低 1.10
- 每 手 1
- 风险率 4.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amphastar Announced FDA Approval for Teriparatide Injection
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for teriparatide injection, USP 560
12-15 19:05
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
Amneal Pharmaceuticals获FDA批准其1%泼尼松龙乙酸酯眼用悬液，计划于2025年第三季度上市。该药物用于治疗 steroid-responsive ocular inflammation， IQVIA数据显示2025年销售额约为2.01亿美元。
06-12 12:00
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
2024-09-07 01:46
